US stock futures rise on trade deals. S&P 500 and Nasdaq to test record highs.

U.S. stock futures are significantly higher, with the S&P 500 and Nasdaq poised to test record highs, driven by new trade deals including a signed agreement with China and nearing accords with ten other partners. This positive market sentiment is further supported by Nike's shares surging 9.34% pre-market after strong quarterly results, despite the company warning of a $1 billion increase in costs due to tariffs. Investors are also anticipating the release of key personal consumption expenditures (PCE) inflation data.

Analysis

U.S. equity futures are signaling a strong open, with the S&P 500 and Nasdaq poised to challenge record highs, driven primarily by positive developments in international trade policy. The confirmation of a signed trade agreement with China, which includes provisions for rare earths supply, alongside progress toward deals with ten other nations, has fueled broad market optimism. This is reflected in pre-market gains across major indices, with Dow futures up 0.24% and Nasdaq futures leading with a 0.32% rise. However, this bullish sentiment is set against a backdrop of rising inflation concerns and a firming 10-year Treasury yield, which has edged up to 4.273%. The market is now focused on the upcoming Personal Consumption Expenditures (PCE) data, the Fed's preferred inflation gauge, with economists expecting the annual rate to hit 2.3% and core to reach 2.6%, and anticipating further increases. At the corporate level, Nike (NKE) shares surged 9.34% pre-market after beating quarterly earnings expectations, though the company issued a material warning that tariffs will increase costs by $1 billion this fiscal year. In contrast, CorMedix (CRMD) shares fell 10.76% following the announcement of a planned $85 million stock offering, highlighting investor sensitivity to share dilution. Meanwhile, Bakkt Holdings (BKKT) has filed to sell up to $1 billion in securities, indicating a strategic intent to fund potential acquisitions of bitcoin and other digital assets.

Key Decisions for Investors

• Given the market's rally on trade news, investors should closely monitor the upcoming PCE inflation data, as a higher-than-expected figure could dampen sentiment and challenge the recent upward momentum.
• For Nike (NKE), the strong pre-market rally on an earnings beat should be weighed against the significant forward-looking risk of a $1 billion cost increase from tariffs, warranting scrutiny of the company's future margin performance.
• The sharp decline in CorMedix (CRMD) on its stock offering announcement presents a clear example of dilution risk, while Bakkt's (BKKT) capital raise filing signals long-term strategic ambition in the digital asset space but introduces near-term uncertainty.